# 43 - Phase 2A Closeout
## My Health Journey v1 (Batches F1–F5, IA-1–IA-2, PA-1–PA-7) — Version 1.0 — 2026-07-04

> Documentation-only record, produced by Batch 5H / PA-7, the Phase 2A closeout batch
> (docs/29 §13). No new application feature was added and no architecture was changed
> to produce this closeout. The only non-documentation changes this batch made were
> three small, disclosed documentation corrections (§5) closing genuine inconsistencies
> found during the review — no `apps-script/*.gs` file, no `shared/` contract, and no
> patient-facing page was touched. Mirrors the closeout discipline
> docs/27-PHASE-1.5-CLOSEOUT.md, docs/35-FOUNDATION-CLOSEOUT.md, and
> docs/36-IDENTITY-AND-ACCESS-CLOSEOUT.md already established.

---

# 1. Phase 2A Scope

Phase 2A ("My Health Journey v1") is the platform's first real patient-facing product
layer (docs/21 Layer 2) — architecture approved in docs/29-PHASE-2A-TECHNICAL-PLAN.md,
docs/30-ARCHITECTURE-PRINCIPLES.md, docs/31-ADR-INDEX.md, docs/33-DOMAIN-MODEL.md, and
docs/34-ARCHITECTURE-CONSISTENCY-REVIEW.md. Delivered across three sequential
milestones, each with its own closeout record:

- **Foundation** (Batches F1–F5) — infrastructure: shared contracts, the response
  envelope, Patient Identity, session issuance/verification, route protection, and the
  schema-validator-based conformance harness. See docs/35-FOUNDATION-CLOSEOUT.md.
- **Identity & Access** (Batches IA-1–IA-2) — the magic-link login backend: LoginToken
  infrastructure, the request/consume flow, rate limiting, account-enumeration
  protection, and Foundation's first authenticated route (`get_profile`). See
  docs/36-IDENTITY-AND-ACCESS-CLOSEOUT.md.
- **Patient Access** (Batches PA-1–PA-7) — the patient-facing product: `login.html`/
  `verify.html`, the My Health Journey dashboard shell, Consultation History/Timeline,
  Symptom Tracker, Report Upload, public visibility (nav/sitemap/indexing), and this
  closeout batch. Batches PA-1–PA-2 have their own closeout
  (docs/38-PATIENT-ACCESS-DASHBOARD-SHELL-CLOSEOUT.md); PA-3–PA-6 are recorded batch-
  by-batch in docs/29 §16 and the root `CHANGELOG.md`.

A real live deployment to the Apps Script project (`wisehomeopathicmc@gmail.com`) was
also verified against the real Google platform, ahead of this batch, and found and fixed
two real, previously-unverified assumptions — recorded in the root `CHANGELOG.md`'s
"Deployment Verification" entry and confirmed still present in the current code by this
batch (§4).

---

# 2. What This Batch Did

Per its own charter (docs/29 §13's Batch 5H row: "Node validation harness for the new
Apps Script modules... + docs/12, docs/15, docs/24 updates"), this batch:

1. Confirmed the branch is based on the latest `main` (PR #41 merged, PA-6 included),
   the repository is clean, and PA-1–PA-6 remain frozen with zero code drift.
2. Confirmed both deployment-verification fixes (`foundationDetectActualMimeType_()`'s
   magic-number MIME detection, `foundationNormalizeEntryDate_()`'s entry_date
   normalization) are present in `apps-script/FoundationReports.gs` and
   `apps-script/FoundationConsultationHistory.gs`.
3. Re-ran every existing validation suite fresh, with zero code changes: static
   analysis, conformance, Phase 1.5 regression, and all five browser-test suites (§3).
4. Performed a 16-dimension repository consistency review (architecture, repository,
   documentation, domain model, schema, contract, validation coverage, browser-test
   coverage, deployment documentation, TODO/FIXME markers, frozen-file boundaries,
   dependency graph, security documentation, release readiness, technical debt, and
   roadmap alignment) and fixed the three genuine issues it found (§5).
5. Performed the dedicated security review of the magic-link/session-token mechanism
   that docs/29 §11 item 2, docs/32 Part 3, and docs/34 had each required before this
   mechanism could be considered done — tracked as still-pending through the Identity &
   Access closeout and never actually performed until now (§5, §6).

---

# 3. Validation Summary (fresh re-run, this batch)

| Suite | Result |
|---|---|
| `node validation/static-analysis/analyze.js` | PASS — 0 findings across all checks (32 `apps-script/*.gs` files) |
| `node validation/phase-2a-foundation/conformance.js` | PASS — 152/152 |
| `node validation/phase-1-5/validate.js` | PASS — 42/42 |
| `validation/pa-2-dashboard/browser-test.js` | PASS — 32/32 |
| `validation/pa-3-timeline/browser-test.js` | PASS — 29/29 |
| `validation/pa-4-symptom-tracker/browser-test.js` | PASS — 28/28 |
| `validation/pa-5-reports/browser-test.js` | PASS — 32/32 |
| `validation/pa-6-public-nav/browser-test.js` | PASS — 22/22 |

**337 automated checks across 8 suites, 0 failures.** No suite required a code change
to pass — every result above was already true going into this batch; this batch's job
was to prove it, not fix it.

---

# 4. Frozen-File Boundary Confirmation

`git diff` between this branch and `origin/main` (post PR #41 merge) showed zero drift
before this batch's own documentation edits — Foundation, Identity & Access, and
Patient Access PA-1 through PA-6 are exactly as merged, with both deployment-
verification fixes intact. Every PA-1–PA-6 commit's file list was cross-checked against
its own disclosed scope in docs/29 §16 and the root `CHANGELOG.md`; no batch touched a
file outside what it disclosed.

---

# 5. Genuine Inconsistencies Found and Fixed

Three, all documentation-only, none requiring a code change, an architecture change, or
a scope expansion:

1. **A mandated security review was tracked as pending but never performed.** docs/29
   §11 item 2, docs/32 Part 3, and docs/34 each required a dedicated review of the
   magic-link/session-token mechanism before that work could be considered done. It
   never appeared as performed, deferred, or accepted-risk in
   docs/36-IDENTITY-AND-ACCESS-CLOSEOUT.md or anywhere since. **Fix:** performed the
   review (§6), recorded it in docs/15-SECURITY-STANDARDS.md, and marked the
   requirement done (with a pointer to the record) in all three source documents
   instead of leaving it silently stale.
2. **A stale, pre-Phase-1.5 `docs/CHANGELOG.md` still claimed shipped work was
   "Unreleased"/"Planned."** Last touched when docs/25's technical plan moved to
   APPROVED — before Phase 1.5, Foundation, Identity & Access, or any Patient Access
   batch existed. The real, current changelog has been the root `CHANGELOG.md` all
   along (docs/29 §12's own documentation-impact table names it explicitly). **Fix:**
   added a superseded notice at the top of `docs/CHANGELOG.md` pointing to the root
   file as authoritative; left the historical entries below it unchanged as a
   historical record, per docs/00's "remove obsolete information" rule applied to the
   false "current status" framing, not the history itself.
3. **docs/24-ROADMAP.md's "Next" pointer was stale.** It described Batch 5H as "not yet
   started," which stopped being true the moment this batch began. **Fix:** updated
   docs/24 to record Batch 5H / PA-7 as shipped and Phase 2A as closed (this document).

No other genuine inconsistency was found across the other 13 review dimensions —
see the closeout review's own findings for the full per-dimension breakdown (retained
in this batch's PR description, not duplicated here).

---

# 6. Security Review Record

Full record: docs/15-SECURITY-STANDARDS.md, "Security review of the magic-link/
session-token mechanism (PA-7 closeout, 2026-07-04)." Summary: manual code review of
`FoundationLoginTokens.gs`, `FoundationSession.gs`, `FoundationLoginFlow.gs`,
`FoundationRateLimit.gs`, `FoundationRouteGuard.gs`, and `login.html`/`verify.html`,
cross-checked against the existing auth-specific conformance/regression coverage.
**No vulnerabilities found.** Token entropy, hashing, single-use enforcement, expiry,
HMAC signature verification (constant-time comparison), anti-enumeration, rate
limiting, audit logging, URL/history token-stripping, and `sessionStorage`-only
persistence were all independently verified against the source, not merely re-read from
documentation claims.

---

# 7. Deferred / Accepted, Not Reopened

Consistent with docs/00's "do not reopen earlier batches simply because a different
implementation is possible" — these remain open by design, not by omission, and this
batch did not touch them:

- docs/28's final governance sign-off ("Deployment approved") — a clinic decision,
  not a technical or documentation task; consistently disclosed across docs/28, 32, 34.
- Per-IP rate limiting — not implementable on the Apps Script platform (verified
  constraint, not an oversight); per-email limiting is the working mitigation.
- Unified RBAC across the patient-session mechanism and Phase 1.5's `STAFF_ACCESS_CODE`
  gate — not called for at this phase.
- Personal Care Plan, Digital Twin/AI Summaries, Health Milestones — each requires its
  own architecture-freeze pass before implementation; explicitly out of Phase 2A scope
  (docs/32 Part 2, docs/24 Phase 2B/2C/2D).
- Operational provisioning (`PATIENT_SPREADSHEET_ID`,
  `FOUNDATION_SESSION_SIGNING_SECRET`) — outside this repository, same treatment as
  Phase 1.5.

---

# 8. Final Project Statistics (Phase 2A)

- **Completed batches:** 14 — F1–F5 (5), IA-1–IA-2 (2), PA-1–PA-7 (7).
- **Validation suites:** 8 — static analysis, conformance, Phase 1.5 regression, and 5
  browser-test suites (PA-2 through PA-6).
- **Total automated checks:** 337 (0 static-analysis findings + 152 conformance + 42
  Phase 1.5 regression + 143 browser-test checks across the 5 browser suites).
- **Documentation closeout reports:** 4 — docs/35 (Foundation), docs/36 (Identity &
  Access), docs/38 (Patient Access Dashboard Shell), docs/43 (this document, Phase 2A).
- **Shared schemas:** 6 (`shared/schemas/*.json`).
- **Apps Script modules:** 32 (`apps-script/*.gs`).
- **Browser test suites:** 5 (`validation/pa-2-dashboard` through `validation/pa-6-public-nav`).

---

# 9. Is Phase 2A Frozen?

**Yes — software-complete, deployment-verified, and frozen except for genuine bug
fixes**, per docs/00's Definition of Done: code implemented, tests complete (337/337
passing), documentation updated, CHANGELOG current, no contradictions remaining after
this batch's three fixes, repository buildable and clean.

# 10. Is Phase 2A Production-Ready?

**Yes, for the scope docs/29 defines** (patient login, dashboard, Timeline,
Consultation History, Symptom Tracker, Report Upload, public visibility) — verified
against a real live deployment, not only mocked test coverage. The one open item
(docs/28's governance sign-off) governs Phase 1.5's clinic-usage approval specifically,
already disclosed and accepted as a non-blocking, non-technical gap across three prior
documents (§7) — it does not gate Phase 2A's own software readiness.

# 11. Does Anything Block Public Release?

No known technical, architectural, schema, contract, or security blocker. See §7 for
what remains open by design.

# 12. Recommendation

**Tag this state `v2.0.0-phase2a`.** Next roadmap milestone: **Phase 2B — Personal Care
Plan** (docs/24), which requires its own architecture-freeze pass (a technical plan and
any new ADRs it needs) before implementation begins — no technical plan exists yet, per
docs/32's recommendation. Do not begin Phase 2B implementation without an explicit,
separate approval.
